Results 201 to 210 of about 48,655 (322)
Physical modification and characterization of starch using pregelatinization and co-process of various tubers from Yogyakarta as an excipient [PDF]
Rizki Awaluddin +5 more
openalex +1 more source
An atom‐by‐atom ternary Cu–Mo–P nanocomposite is electrochemically co‐deposited onto screen‐printed carbon electrodes to create a highly active sensing interface for metformin detection. The porous mixed‐valence network enhances electroactive surface area and charge transfer, enabling sensitive and selective electrooxidation with a low detection limit.
Hong Wan +4 more
wiley +1 more source
Formulation Matters: The Overlooked Engine of Stability and Success in Antibody-Drug Conjugates. [PDF]
Torres-Dias L +3 more
europepmc +1 more source
ABSTRACT The pharmaceutical market has recently witnessed the advent of a novel tetrahydrotriazene molecule belonging to the new pharmacological class “Glimins”, named Imeglimin (IMG). It has been approved in Japan as a safe and highly effective oral diabetic drug for type II diabetic patients.
Mina Wadie +5 more
wiley +1 more source
Differentiating Resistance from Formulation Failure: Isoniazid Instability and Poor Dissolution in Crushed Multi-Drug Paediatric Preparations. [PDF]
Samsodien H +3 more
europepmc +1 more source
Schematic illustration of the development, optimization, and therapeutic evaluation of the Leucas aspera phytosome‐based thermogel for topical antipsoriatic therapy, highlighting its enhanced solubility, skin deposition, and in vivo efficacy in an imiquimod‐induced psoriasis model. Created with BioRender.com.
Ananda Kumar Chettupalli +2 more
wiley +1 more source
Microwave-Assisted Wet Granulation for Engineering Rice Starch-Mannitol Co-Processed Excipients for Direct Compression of Orally Disintegrating Tablets. [PDF]
Trisopon K, Saokham P.
europepmc +1 more source
A Framework for Emergency Department–Integrated Hepatitis C Test‐and‐Treat in the United States
ABSTRACT Despite the availability of curative, direct‐acting antiviral therapy, hepatitis C virus elimination remains incomplete. Losses across the care cascade continue to limit impact, from initial diagnosis to sustained virologic response. Fewer than 1/3 of individuals ultimately achieve cure. These gaps reflect a delivery system that does not align
Saeed S. Graham
wiley +1 more source

